Ares Capital Corporation (ARY) stock prices updated...
 

Ares Capital Corporation stock price

Ares Capital Corporation latest news:


  • 02/14/2018 16:05:15

    BRIEF-Pershing Square Capital Management Takes Sole Share Stake In Nike, Raises Sole Share Stake In Mondelez

    Nike Inc(NKE): * PERSHING SQUARE CAPITAL MANAGEMENT TAKES SOLE SHARE STAKE OF 5.8 MILLION CLASS B SHARES IN Nike Inc(NKE) - SEC FILING. * PERSHING SQUARE CAPITAL MANAGEMENT RAISES SOLE SHARE STAKE IN MONDELEZ INTERNATIONAL TO 23.3 MILLION CLASS A SHARES FROM 13.9 MILLION CLASS A SHARES.

  • 02/12/2018 09:01:24

    GE's stock pares gains; J.P. Morgan analyst gets more bearish

    Shares of General Electric Co. ticked up 0.2% in morning trade, paring earlier gains of as much as 1.3%. J.P. Morgan analyst Stephen Tusa cut his stock price target to $14 from $16, while reiterating the underweight rating he's had on the stock since May 2016, citing continued underperformance in its businesses, challenged fundamentals and lack of many signs of a "snap back." He said he expects an "expedited evolution of outcomes" at GE, after the company said it was evaluating portfolio structure. He said it's possible the company will stay in its current form and "grind it out," but he believes there is more "urgency" to GE's situation given the recent weakness in GE bonds and balance sheet challenges. He said there is a risk of an equity raise, as it would help boost its balance sheet and would shield the company from increased capital markets volatility. "In other words, it's either a steady grind in uncertain markets, with risk that things get more extreme in more volatile capital markets, or it's a change in structure to try and de-risk, and simplify the portfolio to grow it in a more focused way in the future, and we see a bit of a mix," Tusa wrote in a research note. The stock has plunged 26.9% over the past three months, while the Dow Jones Industrial Average has gained 4.2%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/09/2018 08:08:05

    Sarepta stock drops 6% after report of halted trial due to 'serious adverse event'

    Sarepta Therapeutics Inc. shares dropped 6% in extremely heavy morning trade Friday after a report by new analysis service EP Vantage said that the biotech had halted treatment at United Kingdom sites testing its golodirsen therapy due to "one serious adverse event" that could be related to the therapy. Golodirsen is a Duchenne muscular dystrophy therapy intended for boys with the gene that's amenable to skipping exon 53, and positive trial results last fall have had Wall Street hoping for faster-than-normal approval of the therapy. The issue in the UK trial was reportedly rhabdomyolysis, a breakdown of damaged skeletal muscle, according to EP Vantage. Sarepta told EP Vantage that the trial's dosing was halted because of "UK-specific stopping rules," and the company is asking the UK to restart dosing. Wall Street largely brushed off the news on Friday, with analysts describing the development as "may not be material," "unlikely to be major issue" and the stock decline as "likely an overreaction." After speaking with Sarepta, RBC Capital Markets analyst Brian Abrahams said the company told him that the patient had fallen before infusion of the therapy, which means the side effect could be related to the fall or the disease itself, not necessarily the medication. The temporary dose halt could affect the trial's eventual data, but it is not a huge problem because only six patients are enrolled in the UK of about 99 patients total, he said. Sarepta shares have lifted 3.1% over the last three months, compared with a 0.9% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/07/2018 16:03:02

    BRIEF-Development Capital Resources Announces $750 Mln Infrastructure Joint Venture With California Resources Corp

    Ares Management LP(ARES): * DEVELOPMENT CAPITAL RESOURCES ANNOUNCES $750 MILLION INFRASTRUCTURE JOINT VENTURE WITH CALIFORNIA RESOURCES CORPORATION Source text for Eikon: Further company coverage:

  • 02/07/2018 14:23:10

    BRIEF-Golub Capital Qtrly Earnings Per Share ‍$0.36​

    Golub Capital Bdc Inc(GBDC): * GOLUB CAPITAL BDC, INC. DECLARES FISCAL YEAR 2018 SECOND QUARTER DISTRIBUTION OF $0.32 PER SHARE AND ANNOUNCES FISCAL YEAR 2018 FIRST QUARTER FINANCIAL RESULTS. * GOLUB CAPITAL BDC INC QTRLY EARNINGS PER SHARE ‍$0.36​. * GOLUB CAPITAL BDC INC QTRLY ‍NET INVESTMENT INCOME PER SHARE $0.31​ Source text for Eikon: Further company coverage:

  • 02/01/2018 14:24:25

    Amgen shares drop 4% after Q4 profit, revenue misses

    Amgen Inc. shares declined 4.3% after-hours on Thursday after the company reported fourth-quarter profit and revenue misses. The company reported a loss of $4.26 billion, or a loss of $5.89 per share, after earnings of $1.94 billion, or $2.59 per share in the year-earlier period. Adjusted earnings-per-share were $2.89, compared with the FactSet consensus of $3.03. The latest results include a $6.1 billion charge related to the U.S.'s corporate tax overhaul. Revenue declined to $5.80 billion from $5.97 billion, compared with the FactSet consensus of $5.85 billion. Sales of Neulasta, Enbrel, Prolia, Epogen, Kyprolis, Nplate and Neupogen beat the FactSet consensus, while sales of Repatha, Aranesp, Sensipar, Xgeva, Vectibix and Blincyto missed the consensus. Amgen expects 2018 revenue of $21.8 billion to $22.8 billion, compared with the FactSet consensus of $22.86 billion, and 2018 adjusted EPS of $12.60 to $13.70, compared with the FactSet consensus of $12.71. Amgen said its board also authorized $10 billion in share buybacks this month, in addition to the $4.4 billion in share buybacks from late last year.The company also touted plans for $3.5 billion in capital expenditures over the next five years, three-quarters of which is intended for the U.S., a 50% increase from recent years. It includes up to $300 million for a new U.S. manufacturing plant, which should employ about 220 individuals to build, and employ up to 300 skilled full-time employees, with a location finalized in the second quarter. Amgen shares have risen 5.8% over the last three months, compared with a 9.4% rise in the S&P 500 and a 11.5% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/01/2018 10:23:27

    Take-Two stock drops following announcement of second Red Dead Redemption 2 delay

    Shares of Take-Two Interactive Software Inc. are down 2.9% in Thursday trading after the company said that it has delayed the release of of its Red Dead Redemption 2 title until October. The game has already been delayed once before, as it was originally slated to launch last October before the company pushed that back as well. "Getting the long tail of the game correct is more important than recognizing the units two quarters earlier," wrote KeyBanc Capital Markets analyst Evan Wingren, who rates the stock at overweight with a $144 target. "We'd take advantage of the weakness on that belief." The game will now be released in the same quarter as a new Call of Duty from Activision Blizzard Inc. and a new Battlefield from Electronic Arts Inc. , he added. Wingren had predicted, before the delay announcement, that Take-Two would sell 20 million units in the year following its launch. Red Dead Redemption 2 has been considered a key catalyst for shares of Take-Two, which also publishes the Grand Theft Auto Franchise. Take-Two's stock is up 127% over the past 12 months, while the S&P 500 Index is up 24%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/01/2018 06:35:47

    One Stop Systems prices IPO at $5 a share, below price range

    One Stop Systems, Inc. , a provider of ultra-dense high-performance computing systems, said Thursday it has priced its initial public offering at $5 a share, just below its $6 to $8 price range. The company sold 3.8 million shares to raise $19 million. shares will start trading later Thursday on Nasdaq under the ticker symbol "OSS." Roth Capital Partners was sole book-running manager on the deal and Benchmark was co-manager. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/30/2018 05:05:49

    Pfizer shares rise after Q4 profit, revenue beats; upbeat guidance

    Pfizer Inc. shares rose 1.4% in premarket trade Tuesday after the company reported fourth-quarter profit and revenue beats and upbeat 2018 guidance. Earnings for the latest quarter rose rose to $12.27 billion, or $2.02 per share, from $775 million, or 13 cents per share in the year-earlier period. Adjusted earnings-per-share were 62 cents, compared with the FactSet consensus of 56 cents. Revenue rose to $13.70 billion from $13.63 billion, compared with the FactSet consensus of $13.67 billion. The latest results include "continued strength" from products such as Ibrance, Eliquis and Xeljanz, Chief Executive Ian Read said. The company's Essential Health business had strong revenue growth in emerging markets and biosimilars but was hurt by the company's Hospira Infusion Systems divestitute, expected losses of exclusivity for products and Hospira U.S. product shortages, Read said. Pfizer expects 2018 revenue of $53.5 billion to $55.5 billion, compared with the FactSet consensus of $53.82 billion, and 2018 adjusted EPS of $2.90 to $3.00, compared with the FactSet consensus of $2.78. The company said its 2018 financial guidance for the effective tax rate on adjusted income, which it expects to be about 17%, reflects corporate tax reform; Pfizer expects a "meaningfully lower" effective tax rate this year and repatriation tax liability of about $15 billion over eight years. Pfizer also said its 2018 adjusted EPS expectations include an expected $5 billion in share buybacks, and touted its U.S. investments, including plans to invest about $5 billion in capital projects in the U.S. Company shares have surged 11% over the last three months, compared with a 10.9% rise in the S&P 500 and a 13.2% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/29/2018 07:59:47

    Ballard Power's stock rockets after upbeat outlook, dispute of short-seller's report

    Shares of Ballard Power Systems Inc. shot up 19% in morning trade Monday, after the fuel cell company provided an upbeat outlook for 2017 results as it disputed a report by a short seller that led to a sharp selloff last week. Ballard said it expects to report "record annual revenue" for 2017. "We believe these results fully validate our long-held belief that Ballard is uniquely positioned to capitalize on the worldwide trend toward zero-emission transportation," Chief Executive Randy MacEwen said. The stock had tumbled 21% the past two sessions to close Friday at a five-month low, after short-seller Spruce Point Capital Management said the company's growth ambitions in China were expected to fail from weak partnerships, and reminded investors that a previous China deal resulted in a contract breach and lowered guidance in 2015. Spruce Point said the stock should trade in a range of $1.15 to $2.50 over the long term. Ballard said Monday that some of the statements that the short-seller based its arguments on are "demonstrably false," while others amounted to "unduly negative speculation" about "well-disclosed" risks. The stock has run up 87% over the past 12 months, while the S&P 500 has gained 25%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/26/2018 07:00:51

    AbbVie shares rise 3% after Q4 profit, revenue beats, upbeat guidance

    AbbVie Inc. shares rose nearly 3% in pre-market trade after the company reported fourth-quarter profit and revenue beats and released upbeat 2018 guidance. Earnings for the latest quarter declined to $52 million, or 3 cents per share, from $1.39 billion, or 85 cents per share in the year-earlier period. Adjusted earnings-per-share were $1.48, compared with the FactSet consensus of $1.45. Revenue rose to $7.74 billion from $6.80 billion, compared with the FactSet consensus of $7.51 billion. Sales of Humira, Imbruvica, Lupron, Creon, Synagis, Kaletra, Sevoflurane and Duodopa came in above FactSet expectations, while sales of Synthroid and AndroGel missed expectations. AbbVie expects 2018 EPS of $6.45 to $6.55, compared with the FactSet consensus of $5.83, and raised adjusted EPS from between $6.37 and $6.57 to between $7.33 and $7.43, compared with the FactSet consensus of $6.66. The company said its 2017 results reflect provisional amounts related to U.S. corporate tax reform, but that estimates might be adjusted this year. AbbVie also touted plans to increase U.S. investments, including a proposal to invest about $2.5 billion in U.S. capital projects, possible expansion of its U.S. facilities, a one-time charitable donation of about $350 million to U.S. non-profits in 2018, added pension funding of about $750 million and greater compensation for non-executive employees. AbbVie shares have surged 20.9% over the last three months, compared with a 10.9% rise in the S&P 500 and a 12.8% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/25/2018 09:05:00

    Large public sector banks' shares tank as Rs 880-bn recap plan disappoints

    Shares of large public sector banks (PSBs) fell sharply on Thursday after the government's Rs 880-billion capital infusion plan disappointed investors. Shares of State Bank of India (SBI) and Union Bank of India fell five per cent each, Punjab National Bank (PNB) fell the most at 7.1 per cent and Bank of Baroda and Union Bank of India dropped six per cent each. In contrast, smaller PSBs, including UCO Bank and Punjab & Sind Bank ended with gains. A day earlier, shares of all state-owned banks had rallied ahead of the recapitalisation (recap) announcement. The centre on Wednesday announced the much-awaited capital infusion plan under it will invest a total of Rs 800 billion across 21 PSBs through recap bonds. This is in addition, of the Rs 80 billion the government has invested in some banks. Separately, banks have raised Rs 120 billion by way of qualified institutional placement (QIPs) and by divesting holdings in non-core businesses. All this put together, would result in 50 per .

  • 01/23/2018 14:31:36

    Capital One shares fall after surprise quarterly loss

    Shares of Capital One Financial Corp. fell more than 2% late Tuesday after the credit card company reported mixed quarterly results that included a surprise GAAP per-share loss. Capital One said it lost $971 million, or $2.17 a share, in the fourth quarter, versus a net income of $791 million, or $1.45 a share, in the fourth quarter of 2016. Excluding one-time items, the company earned $1.62 a share. Revenue rose to $7.01 billion, compared with $6.56 billion a year ago. Analysts polled by FactSet had expected adjusted earnings of $1.45 a share on sales of $7.09 billion. Shares ended the regular trading day up 0.2%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/17/2018 15:32:28

    BRIEF-Canopy Growth Corp Announces $175 Million Bought Deal Financing

    Canopy Growth Corp(TWMJF): * CANOPY GROWTH CORPORATION ANNOUNCES $175 MILLION BOUGHT DEAL FINANCING. * Canopy Growth Corp(TWMJF) - UNDERWRITERS TO PURCHASE, ON BOUGHT DEAL BASIS, 5.1 MILLION COMMON SHARES OF CO AT $34.60 PER COMMON SHARE. * Canopy Growth Corp (TWMJF) - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR CAPITAL EXPENDITURES FOR CAPACITY EXPANSION Source text for Eikon: Further company coverage:

  • 01/16/2018 09:14:00

    BRIEF-Sagittarius Capital Announces Letter Of Intent With Israeli-Based Irri-Al-Tal

    Sagittarius Capital Corp: * SAGITTARIUS CAPITAL ANNOUNCES LETTER OF INTENT WITH ISRAELI-BASED IRRI-AL-TAL LTD. * SAGITTARIUS CAPITAL SAYS IRRI-AL-TAL WILL EXCHANGE ALL ITS ISSUED AND OUTSTANDING COMMON SHARES FOR COMMON SHARES IN CAPITAL OF SAGITTARIUS. * SAGITTARIUS CAPITAL SAYS IRRI-AL-TAL WILL BECOME A WHOLLY-OWNED SUBSIDIARY OF SAGITTARIUS Source text for Eikon: Further company coverage:

  • 01/16/2018 09:04:23

    Ciena stock rises after Goldman Sachs upgrades to buy

    Shares of telecom equipment supplier Ciena Corp. rose 3.2% in Tuesday morning trading following an upgrade to buy from analysts at Goldman Sachs. "We view Ciena as a key beneficiary of a more bullish outlook on US carrier capital expenditures, improving competitive environment, and a lower bar of expectations as investors adjust to an environment of decelerating optical market growth," wrote the analysts, led by Doug Clark. Ciena has heavy exposure to AT&T and Verizon, he wrote. Stein thinks that tax reform and 5G investments could also provide a boost to the stock. Ciena shares have lost 7.5% in the past 12 months, while the S&P 500 has gained 23%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/16/2018 08:03:28

    AveXis shares drop 6% on company's plans to offer up to $400 mln shares in public offering

    AveXis Inc. shares dropped 6.4% in moderate morning trade Tuesday after the company announced plans for an up to $400 million secondary offering. AveXis also plans to grant the underwriters -- joint book-running managers Goldman Sachs, Jefferies and BofA Merrill Lynch and lead manager BMO Capital Markets -- an option to buy up to $60 million in additional shares of common stock at the public offering price. AveXis also announced on Tuesday plans to expand its clinical development program for spinal muscular atrophy gene therapy candidate AVXS-101. AveXis shares have surged 7.8% over the last three months, compared with a 9.7% rise in the S&P 500 and a 12.4% rise in the Dow Jones Industrial Average. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/16/2018 07:36:57

    Amazon stock rises after BMO raises price target to new Street high

    Shares of Amazon.com Inc. gained 1.8% in Tuesday morning trading after analysts at BMO Capital Markets raised their price target on shares to $1,600, the highest among analysts tracked by FactSet. The analysts, led by Daniel Salmon, are upbeat about Amazon's advertising opportunities and believe that the ad business represents an $18 billion total addressable market "in the midterm." He thinks Amazon could eventually generate 22% of its total gross merchandise value from direct response ads. Separately, analysts at Oppenheimer raised their price target to $1,450 and named Amazon their "top large-cap pick" for the year. "Amazon is best positioned among our large-cap universe to benefit from secular trends - shift to e-commerce, public cloud, automation and digital advertising - further supported by an improving global macroeconomic backdrop and domestic tax reform," wrote the analysts, led by Jason Helfstein. Amazon shares have gained 11.6% so far this year, compared with a 4.8% gain for the S&P 500 Index .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/12/2018 16:23:21

    Blank-check co. Crescent Funding seeks up to $288 million in IPO

    Crescent Funding Inc. seeks to raise up to $288 million in an initial public offering, according to a filing late Friday with the Securities and Exchange Commission. The Los Angeles-based blank check company plans to sell up to 28.75 million shares at $10 a piece. The company formed to effect "a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses," but has yet to identify and potential targets. UBS Investment Bank, Bank of America Merrill Lynch, and Stifel are listed among the underwriters. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/11/2018 08:17:06

    BRIEF-Capgen Capital Group VI LLC Reports 7.3 Pct Stake In Union Bankshares

    Union Bankshares Corp(UBSH): * CAPGEN CAPITAL GROUP VI LLC REPORTS 7.3 PERCENT STAKE IN UNION BANKSHARES CORP AS OF JANUARY 1 - SEC FILING. * CAPGEN CAPITAL GROUP VI LLC SAYS ACQUIRED UNION BANKSHARES' COMMON STOCK FOR INVESTMENT PURPOSES Source text : http://bit.ly/2EyhUmn Further company coverage:

  • 01/10/2018 07:36:33

    AMC stock downgraded, as analyst says 2018 box office revenue could be flat

    Shares of theater chain AMC Entertainment Holding Inc. were down more than 2% in premarket trade on Wednesday after being downgraded to sector perform from outperform at RBC Capital Markets. RBC analysts wrote in a note that their tepid view of the 2018 box office and AMC's high leverage make for a challenging combination for the company. "We'd likely get more bullish on AMC if the box office outlook (given its leverage) and, or there was traction on the international IPO," lead analyst Leo Kulp wrote. "As was evidenced in 2017, AMC's leverage makes it very susceptible to changes in multiple. We estimate a one point EV/EBITDA multiple change has a 36% impact on the stock price. While this is a positive in an up year for the box office, the uncertainty around the 2018 box office makes us more conservative." Kulp expects that the 2018 box office will be flat compared with 2017, which was down slightly from the last two years. They said they see fewer big event films being released this year, and instead more non-sequel content, which could be a negative or a positive depending on how the shift in the box office is received. Shares of AMC have declined more than 59% in the last 12 months, while the S&P 500 index is up more than 21% and the Dow Jones Industrial Average is up nearly 28%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/28/2017 21:36:38

    BRIEF-Nanya Technology disposes stake in Micron Technology for $19.1 mln

    Nanya Technology Corp. * Says it disposes 451,000 shares of Micron Technology Inc (MU), at the average price of approximately $42.430093 per share, for approximately $19.1 million in total, for working capital supplement and loan repayment. * Gains from the stake sale is about $11.3 million. Source text in Chinese:https://goo.gl/LCedSq. Further company coverage:

  • 12/26/2017 06:56:45

    Cannabis company India Globalization Capital shares soar on blockchain announcement

    Shares of India Globalization Capital Inc. rocketed 135% in premarket trading Tuesday after the company announced that it would begin using blockchain in its business. The firm, which is working on a cannabis treatment for Alzheimer's disease, said in a release that it would "leverage its existing team of technology and healthcare experts to develop methods utilizing blockchain in areas such as product identification assurance." India Globalization Capital becomes the latest company to see its shares soar after announcing an interest in using blockchain. As of Friday's close, its stock was up 136% this year. The S&P 500 Index is up 20% so far in 2017.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/24/2017 21:06:07

    BRIEF-Nanya Technology disposes 779,403 shares of Micron Technology for $34.7 mln

    Nanya Technology Corp. * Says it disposes 779,403 shares of Micron Technology Inc (MU), at the price of $34.7 million in total, for working capital supplement and loan repayment. * Says gain on sales of these shares about $21.2 million. Source text in Chinese: https://goo.gl/ftbECS. Further company coverage:

  • 12/21/2017 09:59:46

    Bed Bath & Beyond shares tumble 12.3% after "weak" earnings announcement

    Bed Bath & Beyond Inc. shares fell 12.3% in Thursday trading after the home goods retailer reported third-quarter earnings that Credit Suisse analysts call "weak." Earnings per share of 44 cents beat the 37-cents FactSet consensus, but were down from 85 cents last year. Earnings before interest and taxes (EBIT) was down 350 basis points, "the largest decline to date, validating our concerns on the rising cost of doing business in this sector." Credit Suisse rates Bed Bath & Beyond shares neutral with a $25 price target. KeyBanc Capital Markets also highlighted the "significant competitive headwinds" that will put pressure on the margins over the near-term. "Factors that have pressured results in recent years are likely to continue," analysts wrote. KeyBanc rates Bed Bath & Beyond shares underweight with a $17 price target. "[M]anagement highlighted that it is going to place more emphasis on its value proposition to consumers, including returning to price match guarantees, more responsive pricing at the brick & mortar stores, and adding more low-priced/treasure hunt items to emulate concepts that have succeeded in the current environment such as dollar stores," wrote BTIG analysts. They rate the company's shares neutral. Bed Bath & Beyond shares are down 52.7% for the past year while the S&P 500 index is up 18.8% for the period.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/20/2017 07:00:56

    Net Element's stock soars 144% after announcing launch of blockchain business

    Shares of Net Element Inc. more than doubled on heavy volume in premarket trade Wednesday, after the electronic payments company said it was launching a blockchain-focused business unit. The company said it has partners with Bunker Capital to develop a decentralized crypto-based ecosystem that will act as a framework for services that can connect merchants and consumers directly using blockchain technology. "We believe that we're at the dawn of a new evolution where additional digital payment methods are being introduced," said Net Element Chief Executive Oleg Firer. The stock traded up 144% on volume of 875,000 shares ahead of the open, compared with the full-day average for volume of 458,000 shares. The stock had tumbled 30.5% year to date through Tuesday, while the S&P 500 had climbed 19.8%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/19/2017 19:33:18

    BRIEF-Nanya Technology disposes 4.5 mln shares of Micron Technology for $195.2 mln

    Nanya Technology Corp. * Says it disposes 4.5 million shares of Micron Technology Inc (MU) at the price of $195.2 million in total, for working capital supplement and loan repayment. Source text in Chinese: https://goo.gl/CqCvgY. Further company coverage:

  • 12/17/2017 19:18:16

    BRIEF-Nanya Technology disposes 856,586 shares of Micron Technology for $36.3 mln

    Nanya Technology Corp. * Says it disposes 856,586 shares of Micron Technology Inc (MU) at the price of $36.3 million in total, for working capital supplement and bank loan repayment. Source text in Chinese: https://goo.gl/PvRhfS. Further company coverage:

  • 12/14/2017 07:24:47

    PayPal stock rises as analyst cheers Venmo opportunities

    Shares of PayPal Holdings Inc. gained 0.5% in premarket trading Thursday after an analyst at KeyBanc Capital Markets named the payment-processor a "key idea" for 2018. KeyBanc's Josh Beck is upbeat on the company's efforts to monetize its Venmo peer-to-peer payment platform by letting users pay for e-commerce items using the Venmo app. " The Pay with Venmo opportunity brings in incremental customers with higher profit margins and is well positioned to scale," he wrote in a note to clients Wednesday. Beck has a $90 price target on PayPal shares. His other "key idea" in payments is Vantiv Inc. , as he sees opportunities for the company to drive better-than-expected synergies from its Worldpay deal. PayPal shares have gained 88% so far in 2017, while Vantiv's stock is up 23%. The S&P 500 also rose 23% in that time.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/14/2017 06:05:08

    BRIEF-Brookfield Capital Partners Says Co And Certain Affiliates Bought 122.6 Mln Common Shares Of CWC Energy Services

    Cwc Energy Services Corp(CAWLF): * BROOKFIELD CAPITAL PARTNERS LTD SAYS IT AND CERTAIN OF ITS AFFILIATES ACQUIRED 122.6 MILLION COMMON SHARES OF Cwc Energy Services Corp(CAWLF). * BROOKFIELD CAPITAL PARTNERS - BROOKFIELD CAPITAL ACQUIRED THE SHARES OF CWC ENERGY SERVICES AT $0.20 PER COMMON SHARE FOR ABOUT $24.5 MILLION.

  • More trends:

    Ares Commercial Real Estate CorporationACRE | Ares Dynamic Credit Allocation FundARDC | Ares Management L.P.ARES | Ares Multi-Strategy Credit FundARMF | ArganAGX | Arista NetworksANET | Arlington Asset Investment CorpAI | Arlington Asset Investment CorpAIC | Arlington Asset Investment CorpAIW | Armada Hoffler PropertiesAHH |